UPDATE: Greece Joins EU States Limiting AstraZeneca Vaccine

(Alliance News) - Greece on Friday joined other EU states in limiting use of AstraZeneca PLC's ...

Alliance News 5 February, 2021 | 8:06PM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Greece on Friday joined other EU states in limiting use of AstraZeneca PLC's Covid-19 vaccine to those under age 65, awaiting more data on its efficacy on the elderly.

"In Greece, as in other EU countries, the AstraZeneca vaccine will be used on ages 18-64," health ministry general secretary Marios Themistokleous told reporters.

There is "insufficient evidence" regarding its use on older people, he said.

France, Germany, Belgium, Denmark, Sweden and other countries have so far put age limits on the vaccine, which was developed by the British-Swedish firm with Oxford University.

Nearly 6,000 deaths in Greece have been attributed to coronavirus since the start of the pandemic, including a 16-year-girl on Wednesday. Over 240 people are in intensive care.

Fewer than 360,000 vaccinations have been carried out in the country of 11 million.

Those aged 60 to 64 are expected to receive inoculation after February 12, Themistokleous said.

Health safety officials on Friday again imposed some restrictions in an ongoing lockdown that had been relaxed over Christmas.

A 6 pm curfew was imposed this weekend in Athens and Thessaloniki, and high schools were closed until February 15, a week after reopening.

Vana Papaevangelou, a member of the state coronavirus expert committee, said that average daily cases had increased to nearly 900 this week from 625 a week earlier nationwide.

"The map is red again, in many areas," she told reporters.

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
AstraZeneca PLC 11,248.00 GBX -0.02

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures